A security guard at Delhi’s AIIMS developed an allergic reaction, or anaphylaxis after being administered COVID-19 vaccine shot on the first day of the nationwide inoculation drive. Anaphylaxis causes a series of symptoms, including a rash, low pulse, and shock, if not treated promptly.
The worker has been kept under observation of doctors at the hospital, media quoted an AIIMS official as saying.
The 20-year-old was administered a jab of COVID-19 vaccine ‘Covaxin’, one of the two vaccines that have been approved by the country’s drug controller for restricted emergency use as of now.
Indigenously-developed COVID-19 vaccine – Covaxin – is produced by Hyderabad-based Bharat Biotech. It was delivered to 12 states across the country ahead of the launch of the vaccination drive.
As per the AIIMS official, a total of 95 healthcare beneficiaries were given the COVID-19 vaccine at Delhi’s hospital on 16 January.
A senior NDMC official, who asked not to be named, said two cases of mild AEFI (adverse effects following immunisation) symptoms were reported at Charak Palika Hospital. Two of the hospital’s health care workers who took the Covid-19 vaccine in the afternoon, reported slight tightness in the chest during the observation period.
“They were immediately attended to by the AEFI team and kept under observation. They felt normal within half-an-hour and were discharged. There is nothing to be worried about AEFI cases, as such symptoms are normal to occur after any vaccination,” the official said.
Hospitals across the city said they were equipped to deal with any adverse events.
At Lok Nayak, two consultation rooms in the observation area were converted to high-dependence units with all emergency medications and oxygen support available.
“The rooms are like mini emergency centres in themselves and can handle any adverse events that may take place during vaccination. The patient will not even have to be moved from the vaccination site,” said Dr Suresh Kumar, the hospital’s medical director.
At GTB hospital, intensive care unit beds were kept ready just above the vaccination site on the first floor of the emergency building. And at Ram Manohar Lohia hospital, a resuscitation centre was set up – similar to the one in Lok Nayak – at the vaccination site, which was also close to the ICU facility at the hospital.
A total of 4,319 healthcare workers were administered COVID-19 shot against the target of 8,117 in the national capital. The vaccination drive was held at 81 sites in the city.
The national capital reported 1 severe reaction and 51 minor reactions such as rashes, swelling at the site of injection, or fever. The total number of adverse events following immunisation (AEFI) post-COVID-19 vaccine in Delhi stands at 52 out of which only one is severe, said the Delhi government on 16 January.
At least 1,91,181 healthcare workers received COVID-19 shot yesterday across the country during the mega drive which the Centre said is “probably the beginning of the end”.
The mega vaccination programme was launched by Prime Minister Narendra Modi at 3,006 session sites across all states and Union territories.
Bharat Biotech, which has received a purchase order from the Central government for the supply of 55 lakh doses of Covaxin, has said that the company will compensate in case of any adverse effects experienced by recipients.
“In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals. The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” Bharat Biotech said in its consent form, according to news agency.